Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

279 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Complexity index in sarcoma and genomic grade index gene signatures in rhabdomyosarcoma of pediatric and adult ages.
Ferrari A, Iannó MF, Carenzo A, Fortunato O, Casanova M, Chiaravalli S, Bergamaschi L, Bertulli R, Cattaneo F, Collini P, Trama A, Sozzi G, Massimino M, De Cecco L, Gasparini P. Ferrari A, et al. Among authors: de cecco l. Pediatr Blood Cancer. 2021 Jul;68(7):e28987. doi: 10.1002/pbc.28987. Epub 2021 Mar 10. Pediatr Blood Cancer. 2021. PMID: 33751795
Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood.
Massimino M, Biassoni V, Miceli R, Schiavello E, Warmuth-Metz M, Modena P, Casanova M, Pecori E, Giangaspero F, Antonelli M, Buttarelli FR, Potepan P, Pollo B, Nunziata R, Spreafico F, Podda M, Anichini A, Clerici CA, Sardi I, De Cecco L, Bode U, Bach F, Gandola L. Massimino M, et al. Among authors: de cecco l. J Neurooncol. 2014 Jun;118(2):305-312. doi: 10.1007/s11060-014-1428-z. Epub 2014 Apr 3. J Neurooncol. 2014. PMID: 24696052 Clinical Trial.
CDCP1 is a novel marker of the most aggressive human triple-negative breast cancers.
Turdo F, Bianchi F, Gasparini P, Sandri M, Sasso M, De Cecco L, Forte L, Casalini P, Aiello P, Sfondrini L, Agresti R, Carcangiu ML, Plantamura I, Sozzi G, Tagliabue E, Campiglio M. Turdo F, et al. Among authors: de cecco l. Oncotarget. 2016 Oct 25;7(43):69649-69665. doi: 10.18632/oncotarget.11935. Oncotarget. 2016. PMID: 27626701 Free PMC article.
Correction to: Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood.
Massimino M, Biassoni V, Miceli R, Schiavello E, Warmuth-Metz M, Modena P, Casanova M, Pecori E, Giangaspero F, Antonelli M, Buttarelli FR, Potepan P, Pollo B, Nunziata R, Spreafico F, Podda M, Anichini A, Clerici CA, Sardi I, De Cecco L, Bode U, Bach F, Gandola L. Massimino M, et al. Among authors: de cecco l. J Neurooncol. 2018 Jul;138(3):679-680. doi: 10.1007/s11060-018-2893-6. J Neurooncol. 2018. PMID: 29767306
Big Data in Head and Neck Cancer.
Resteghini C, Trama A, Borgonovi E, Hosni H, Corrao G, Orlandi E, Calareso G, De Cecco L, Piazza C, Mainardi L, Licitra L. Resteghini C, et al. Among authors: de cecco l. Curr Treat Options Oncol. 2018 Oct 25;19(12):62. doi: 10.1007/s11864-018-0585-2. Curr Treat Options Oncol. 2018. PMID: 30361937 Review.
Age-Related Alterations in Immune Contexture Are Associated with Aggressiveness in Rhabdomyosarcoma.
Gasparini P, Fortunato O, De Cecco L, Casanova M, Iannó MF, Carenzo A, Centonze G, Milione M, Collini P, Boeri M, Dugo M, Gargiuli C, Mensah M, Segale M, Bergamaschi L, Chiaravalli S, Sensi ML, Massimino M, Sozzi G, Ferrari A. Gasparini P, et al. Among authors: de cecco l. Cancers (Basel). 2019 Sep 17;11(9):1380. doi: 10.3390/cancers11091380. Cancers (Basel). 2019. PMID: 31533233 Free PMC article.
279 results